Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(2-isopropylpyrazolo(1,5-a)pyridin-3-yl)-2-methyl-1-propanone
2. 1-(2-isopropylpyrazolo(1,5-alpha)pyridin-3-yl)-2-methyl-1-propanone
3. 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
4. Av 411
5. Av-411
6. Av411
7. Kc 404
8. Kc-404
9. Mn-166
10. Mn166
1. 50847-11-5
2. Ketas
3. Kc-404
4. Mn-166
5. Ibudilastum
6. Ke Tas
7. Ibudilastum [latin]
8. Av-411
9. Ibudilast [inn:jan]
10. Eyevinal
11. Ketas (tn)
12. 2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one
13. 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine
14. Unii-m0tth61xc5
15. 1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one
16. Av411
17. 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine
18. Tocris-1694
19. Lopac-i-0157
20. 1-propanone, 2-methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-
21. 2-isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine
22. Mfcd00864808
23. M0tth61xc5
24. Chembl19449
25. Kc-404;av-411;mn-166
26. Ncgc00015542-05
27. 2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one
28. 1-propanone, 2-methyl-1-(2-(1-methylethyl)pyrazolo(1,5-a)pyridin-3-yl)-
29. Dsstox_cid_28933
30. Dsstox_rid_83199
31. 2-isopropyl-3-isobutyrylpyrazolo[1,5-a]pyridine
32. Dsstox_gsid_49007
33. Ibudilast (jan/inn)
34. Av 411
35. Cas-50847-11-5
36. Sr-01000075927
37. Brn 0656579
38. Pinatos
39. I0157_sigma
40. 1-(2-isopropylpyrazolo(1,5-a)pyridin-3-yl)-2-methyl-1-propanone
41. Ibudilast,(s)
42. Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-
43. Ibudilast [inn]
44. Ibudilast [jan]
45. Ibudilast [mi]
46. Ibudilast (jp17/inn)
47. Ibudilast [mart.]
48. I 0157
49. Ibudilast [who-dd]
50. Lopac0_000599
51. Schembl30390
52. 5-24-03-00396 (beilstein Handbook Reference)
53. Mls000862198
54. Gtpl7399
55. Zinc4234
56. Dtxsid7049007
57. Chebi:31684
58. Bcpp000209
59. Hms2089b21
60. Hms2233h08
61. Hms3261h20
62. Hms3268o11
63. Hms3374p02
64. Hms3412b20
65. Hms3676b20
66. Hms3715l09
67. Hms3886m03
68. Bcp02335
69. Hy-b0763
70. Tox21_113503
71. Tox21_500599
72. Bdbm50240404
73. S4837
74. Ibudilast, >=99% (hplc), Solid
75. Akos015895123
76. Tox21_113503_1
77. Ac-1044
78. Bcp9000768
79. Ccg-204688
80. Db05266
81. Lp00599
82. Sb19092
83. Sdccgsbi-0050581.p002
84. Ncgc00015542-01
85. Ncgc00015542-02
86. Ncgc00015542-03
87. Ncgc00015542-04
88. Ncgc00015542-06
89. Ncgc00015542-07
90. Ncgc00015542-17
91. Ncgc00025261-01
92. Ncgc00025261-02
93. Ncgc00025261-03
94. Ncgc00025261-04
95. Ncgc00261284-01
96. Smr000326961
97. Sy051343
98. Eu-0100599
99. Ft-0654591
100. Ft-0670255
101. I0740
102. D01385
103. F20666
104. Ab00698306-06
105. 3-isobutyryl-2-isopropyl-pyrazolo(1,5-a)pyridine
106. 847i115
107. A828320
108. H-20256
109. L003042
110. Q261167
111. J-512714
112. Sr-01000075927-1
113. Sr-01000075927-3
114. Sr-01000075927-6
115. Brd-k16444452-001-03-4
116. 1-(2-isopropylh-pyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one
117. 1-(2-isopropyl-pyrazolo[1,5-a]pyridin-3-yl)-2-methyl-propan-1-one
118. 1-(2-isopropyl-pyrazolo[1,5-alpha]pyridin-3-yl)-2-methyl-propan-1-one
119. 1-(2-isopropylpyrazolo[1,5-alpha]pyridin-3-yl)-2-methylpropan-1-one
120. 2-methyl-1-(2-propan-2-yl-3-pyrazolo[1,5-a]pyridinyl)-1-propanone
121. 2-methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-1-propanone
122. (ibudilast)1-(2-isopropyl-pyrazolo[1,5-a]pyridin-3-yl)-2-methyl-propan-1-one
123. 1-(2-isopropylpyrazolo(1,5-.alpha.)pyridin-3-yl)-2-methyl-1-propanone
124. 1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one (ibudilast)
125. Avl
Molecular Weight | 230.31 g/mol |
---|---|
Molecular Formula | C14H18N2O |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 230.141913202 g/mol |
Monoisotopic Mass | 230.141913202 g/mol |
Topological Polar Surface Area | 34.4 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 288 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of multiple sclerosis, asthma, and cerebrovascular disease.
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03D - Other systemic drugs for obstructive airway diseases
R03DC - Leukotriene receptor antagonists
R03DC04 - Ibudilast
19 hours
Ibudilast has mechanisms that include anti-inflammatory effects, such as phosphodiesterase inhibition, and neuroprotective effects, such as inhibition of [nitric oxide] synthesis and reduction in reactive oxygen species.
Market Place
ABOUT THIS PAGE
20
PharmaCompass offers a list of Ibudilast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibudilast manufacturer or Ibudilast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibudilast manufacturer or Ibudilast supplier.
PharmaCompass also assists you with knowing the Ibudilast API Price utilized in the formulation of products. Ibudilast API Price is not always fixed or binding as the Ibudilast Price is obtained through a variety of data sources. The Ibudilast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_28933 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_28933, including repackagers and relabelers. The FDA regulates DSSTox_CID_28933 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_28933 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_28933 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_28933 supplier is an individual or a company that provides DSSTox_CID_28933 active pharmaceutical ingredient (API) or DSSTox_CID_28933 finished formulations upon request. The DSSTox_CID_28933 suppliers may include DSSTox_CID_28933 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_28933 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DSSTox_CID_28933 Drug Master File in Japan (DSSTox_CID_28933 JDMF) empowers DSSTox_CID_28933 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DSSTox_CID_28933 JDMF during the approval evaluation for pharmaceutical products. At the time of DSSTox_CID_28933 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DSSTox_CID_28933 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DSSTox_CID_28933 Drug Master File in Korea (DSSTox_CID_28933 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_CID_28933. The MFDS reviews the DSSTox_CID_28933 KDMF as part of the drug registration process and uses the information provided in the DSSTox_CID_28933 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DSSTox_CID_28933 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_CID_28933 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DSSTox_CID_28933 suppliers with KDMF on PharmaCompass.
DSSTox_CID_28933 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_28933 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_28933 GMP manufacturer or DSSTox_CID_28933 GMP API supplier for your needs.
A DSSTox_CID_28933 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_28933's compliance with DSSTox_CID_28933 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_28933 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_28933 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_28933 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_28933 EP), DSSTox_CID_28933 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_28933 USP).